{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:45:19Z","timestamp":1793454319642,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-024-01860-1","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T05:07:23Z","timestamp":1732079243000},"page":"3254-3267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8957-1392","authenticated-orcid":false,"given":"Mark J. G.","family":"Bakkers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freek","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemart","family":"Koornneef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2161-0835","authenticated-orcid":false,"given":"Daan","family":"van Overveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lam","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0753-8769","authenticated-orcid":false,"given":"Ward","family":"van den Hoogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Vaneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Thoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1935-9377","authenticated-orcid":false,"given":"Richard","family":"Voorzaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisanne","family":"Tettero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarek","family":"Juraszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"van der Fits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8768-0982","authenticated-orcid":false,"given":"Johannes P. M.","family":"Langedijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"1860_CR1","volume":"146","author":"B Rha","year":"2020","unstructured":"Rha, B. et al. Respiratory syncytial virus-associated hospitalizations among young children: 2015\u20132016. Pediatrics 146, e20193611 (2020).","journal-title":"Pediatrics"},{"key":"1860_CR2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/jiaa752","volume":"225","author":"JM McLaughlin","year":"2022","unstructured":"McLaughlin, J. M. et al. Respiratory syncytial virus-associated hospitalization rates among US infants: a systematic review and meta-analysis. J. Infect. Dis. 225, 1100\u20131111 (2022).","journal-title":"J. Infect. Dis."},{"key":"1860_CR3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/QCO.0000000000001000","volume":"37","author":"S Kenmoe","year":"2024","unstructured":"Kenmoe, S. & Nair, H. The disease burden of respiratory syncytial virus in older adults. Curr. Opin. Infect. Dis. 37, 129\u2013136 (2024).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"1860_CR4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/pathogens8020067","volume":"8","author":"MC Pandya","year":"2019","unstructured":"Pandya, M. C., Callahan, S. M., Savchenko, K. G. & Stobart, C. C. A contemporary view of respiratory syncytial virus (RSV) biology and strain-specific differences. Pathogens 8, 67 (2019).","journal-title":"Pathogens"},{"key":"1860_CR5","doi-asserted-by":"crossref","first-page":"e5142","DOI":"10.1097\/MD.0000000000005142","volume":"95","author":"ML Bouzas","year":"2016","unstructured":"Bouzas, M. L. et al. Respiratory syncytial virus a and b display different temporal patterns in a 4-year prospective cross-sectional study among children with acute respiratory infection in a tropical city. Medicine 95, e5142 (2016).","journal-title":"Medicine"},{"key":"1860_CR6","first-page":"83","volume":"372","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S., Ray, W. C. & Peeples, M. E. Structure and function of RSV surface glycoproteins. Curr. Top. Microbiol. Immunol. 372, 83\u2013104 (2013).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"1860_CR7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.virol.2015.03.043","volume":"479\u2013480","author":"SC Harrison","year":"2015","unstructured":"Harrison, S. C. Viral membrane fusion. Virology 479\u2013480, 498\u2013507 (2015).","journal-title":"Virology"},{"key":"1860_CR8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","volume":"340","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340, 1113\u20131117 (2013).","journal-title":"Science"},{"key":"1860_CR9","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1099\/0022-1317-72-12-3095","volume":"72","author":"PL Collins","year":"1991","unstructured":"Collins, P. L. & Mottet, G. Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus. J. Gen. Virol. 72, 3095\u20133101 (1991).","journal-title":"J. Gen. Virol."},{"key":"1860_CR10","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.1073\/pnas.151098198","volume":"98","author":"L Gonz\u00e1lez-Reyes","year":"2001","unstructured":"Gonz\u00e1lez-Reyes, L. et al. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc. Natl Acad. Sci. USA 98, 9859\u20139864 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1860_CR11","doi-asserted-by":"crossref","first-page":"9218","DOI":"10.1128\/JVI.76.18.9218-9224.2002","volume":"76","author":"G Zimmer","year":"2002","unstructured":"Zimmer, G., Conzelmann, K.-K. & Herrler, G. Cleavage at the furin consensus sequence RAR\/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture. J. Virol. 76, 9218\u20139224 (2002).","journal-title":"J. Virol."},{"key":"1860_CR12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.aav9033","volume":"365","author":"MC Crank","year":"2019","unstructured":"Crank, M. C. et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science 365, 505\u2013509 (2019).","journal-title":"Science"},{"key":"1860_CR13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4241","volume":"7","author":"JO Ngwuta","year":"2015","unstructured":"Ngwuta, J. O. et al. Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Sci. Transl. Med. 7, 309ra162 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1860_CR14","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9143","volume":"6","author":"A Krarup","year":"2015","unstructured":"Krarup, A. et al. A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism. Nat. Commun. 6, 8143 (2015).","journal-title":"Nat. Commun."},{"key":"1860_CR15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","volume":"342","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592\u2013598 (2013).","journal-title":"Science"},{"key":"1860_CR16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","volume":"388","author":"A Papi","year":"2023","unstructured":"Papi, A. et al. Respiratory syncytial virus prefusion F protein vaccine in older adults. N. Engl. J. Med. 388, 595\u2013608 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1860_CR17","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","volume":"388","author":"EE Walsh","year":"2023","unstructured":"Walsh, E. E. et al. Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults. N. Engl. J. Med. 388, 1465\u20131477 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1860_CR18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg6050","volume":"15","author":"L Sacconnay","year":"2023","unstructured":"Sacconnay, L. et al. The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains. Sci. Transl. Med. 15, eadg6050 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1860_CR19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40272-023-00606-6","volume":"26","author":"C Verwey","year":"2024","unstructured":"Verwey, C., Dangor, Z. & Madhi, S. A. Approaches to the prevention and treatment of respiratory syncytial virus infection in children: rationale and progress to date. Paediatr. Drugs 26, 101\u2013112 (2024).","journal-title":"Paediatr. Drugs"},{"key":"1860_CR20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOP.0000000000001336","volume":"36","author":"MA Lipp","year":"2024","unstructured":"Lipp, M. A. & Empey, K. M. Recent advances in the prevention of respiratory syncytial virus in pediatrics. Curr. Opin. Pediatr. 36, 182\u2013189 (2024).","journal-title":"Curr. Opin. Pediatr."},{"key":"1860_CR21","first-page":"817","volume":"64","author":"AV Letarov","year":"1999","unstructured":"Letarov, A. V., Londer, Y. Y., Boudko, S. P. & Mesyanzhinov, V. V. The carboxy-terminal domain initiates trimerization of bacteriophage T4 fibritin. Biochemistry 64, 817\u2013823 (1999).","journal-title":"Biochemistry"},{"key":"1860_CR22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00018-017-2715-6","volume":"75","author":"A G\u00f3rski","year":"2018","unstructured":"G\u00f3rski, A. et al. Bacteriophages targeting intestinal epithelial cells: a potential novel form of immunotherapy. Cell. Mol. Life Sci. 75, 589\u2013595 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"1860_CR23","doi-asserted-by":"crossref","first-page":"102209","DOI":"10.1016\/j.coi.2022.102209","volume":"77","author":"PO Byrne","year":"2022","unstructured":"Byrne, P. O. & McLellan, J. S. Principles and practical applications of structure-based vaccine design. Curr. Opin. Immunol. 77, 102209 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"1860_CR24","volume":"15","author":"Y Che","year":"2023","unstructured":"Che, Y. et al. Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine. Sci. Transl. Med. 15, eade6422 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1860_CR25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jmb.2004.02.020","volume":"337","author":"S G\u00fcthe","year":"2004","unstructured":"G\u00fcthe, S. et al. Very fast folding and association of a trimerization domain from bacteriophage T4 fibritin. J. Mol. Biol. 337, 905\u2013915 (2004).","journal-title":"J. Mol. Biol."},{"key":"1860_CR26","volume":"15","author":"KJ Gonzalez","year":"2024","unstructured":"Gonzalez, K. J. et al. A general computational design strategy for stabilizing viral class I fusion proteins. Nat. Commun. 15, 1335 (2024).","journal-title":"Nat. Commun."},{"key":"1860_CR27","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00637-7","volume":"8","author":"E Saeland","year":"2023","unstructured":"Saeland, E. et al. Combination Ad26.RSV.preF\/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models. NPJ Vaccines 8, 45 (2023).","journal-title":"NPJ Vaccines"},{"key":"1860_CR28","volume":"10","author":"MSA Gilman","year":"2019","unstructured":"Gilman, M. S. A. et al. Transient opening of trimeric prefusion RSV F proteins. Nat. Commun. 10, 2105 (2019).","journal-title":"Nat. Commun."},{"key":"1860_CR29","doi-asserted-by":"crossref","first-page":"16271","DOI":"10.1038\/nmicrobiol.2016.271","volume":"2","author":"JJ Mousa","year":"2017","unstructured":"Mousa, J. J., Kose, N., Matta, P., Gilchuk, P. & Crowe, J. E. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein. Nat. Microbiol. 2, 16271 (2017).","journal-title":"Nat. Microbiol."},{"key":"1860_CR30","doi-asserted-by":"crossref","first-page":"e1007944","DOI":"10.1371\/journal.ppat.1007944","volume":"15","author":"HG Jones","year":"2019","unstructured":"Jones, H. G. et al. Alternative conformations of a major antigenic site on RSV F. PLoS Pathog. 15, e1007944 (2019).","journal-title":"PLoS Pathog."},{"key":"1860_CR31","volume":"1","author":"MSA Gilman","year":"2016","unstructured":"Gilman, M. S. A. et al. Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors. Sci. Immunol. 1, eaaj1879 (2016).","journal-title":"Sci. Immunol."},{"key":"1860_CR32","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/acscentsci.2c00981","volume":"8","author":"L Casalino","year":"2022","unstructured":"Casalino, L. et al. Breathing and tilting: mesoscale simulations illuminate influenza glycoprotein vulnerabilities. ACS Cent. Sci. 8, 1646\u20131663 (2022).","journal-title":"ACS Cent. Sci."},{"key":"1860_CR33","unstructured":"Langedijk, J. P. M. et. al. Stabilized pre-fusion RSV FB antigens. WO2022175477 (2022)."},{"key":"1860_CR34","volume":"15","author":"JPM Langedijk","year":"2024","unstructured":"Langedijk, J. P. M. et al. Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein. Nat. Commun. 15, 4629 (2024).","journal-title":"Nat. Commun."},{"key":"1860_CR35","volume":"15","author":"MJG Bakkers","year":"2024","unstructured":"Bakkers, M. J. G. et al. Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer. Nat. Commun. 15, 6270 (2024).","journal-title":"Nat. Commun."},{"key":"1860_CR36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa2207566","volume":"388","author":"AR Falsey","year":"2023","unstructured":"Falsey, A. R. et al. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N. Engl. J. Med. 388, 609\u2013620 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1860_CR37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.coviro.2017.03.012","volume":"23","author":"BS Graham","year":"2017","unstructured":"Graham, B. S. Vaccine development for respiratory syncytial virus. Curr. Opin. Virol. 23, 107\u2013112 (2017).","journal-title":"Curr. Opin. Virol."},{"key":"1860_CR38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/infdis\/jiad321","volume":"229","author":"I Leroux-Roels","year":"2024","unstructured":"Leroux-Roels, I. et al. Safety and immunogenicity of a revaccination with a respiratory syncytial virus prefusion F vaccine in older adults: a phase 2b study. J. Infect. Dis. 229, 355\u2013366 (2024).","journal-title":"J. Infect. Dis."},{"key":"1860_CR39","doi-asserted-by":"crossref","first-page":"11802","DOI":"10.1128\/JVI.01225-14","volume":"88","author":"KA Swanson","year":"2014","unstructured":"Swanson, K. A. et al. A monomeric uncleaved respiratory syncytial virus F antigen retains prefusion-specific neutralizing epitopes. J. Virol. 88, 11802\u201311810 (2014).","journal-title":"J. Virol."},{"key":"1860_CR40","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/infdis\/jiac327","volume":"227","author":"I Leroux-Roels","year":"2023","unstructured":"Leroux-Roels, I. et al. Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults: phase 1\/2 randomized clinical trial. J. Infect. Dis. 227, 761\u2013772 (2023).","journal-title":"J. Infect. Dis."},{"key":"1860_CR41","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1126\/science.1089427","volume":"302","author":"B Kuhlman","year":"2003","unstructured":"Kuhlman, B. et al. Design of a novel globular protein fold with atomic-level accuracy. Science 302, 1364\u20131368 (2003).","journal-title":"Science"},{"key":"1860_CR42","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/ct9000685","volume":"5","author":"MJ Harvey","year":"2009","unstructured":"Harvey, M. J., Giupponi, G. & Fabritiis, G. D. ACEMD: accelerating biomolecular dynamics in the microsecond time scale. J. Chem. Theory Comput. 5, 1632\u20131639 (2009).","journal-title":"J. Chem. Theory Comput."},{"key":"1860_CR43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"1860_CR44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nmeth.2727","volume":"11","author":"A Kucukelbir","year":"2014","unstructured":"Kucukelbir, A., Sigworth, F. J. & Tagare, H. D. Quantifying the local resolution of cryo-EM density maps. Nat. Methods 11, 63\u201365 (2014).","journal-title":"Nat. Methods"},{"key":"1860_CR45","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1860_CR46","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"1860_CR47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"1860_CR48","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. D"},{"key":"1860_CR49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"1860_CR50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nmeth.3541","volume":"12","author":"BA Barad","year":"2015","unstructured":"Barad, B. A. et al. EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy. Nat. Methods 12, 943\u2013946 (2015).","journal-title":"Nat. Methods"},{"key":"1860_CR51","unstructured":"PyMOL by Schr\u00f6dinger (Schrodinger, 2021)."},{"key":"1860_CR52","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1128\/JVI.00555-11","volume":"85","author":"JS McLellan","year":"2011","unstructured":"McLellan, J. S., Yang, Y., Graham, B. S. & Kwong, P. D. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J. Virol. 85, 7788\u20137796 (2011).","journal-title":"J. Virol."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-024-01860-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-024-01860-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-024-01860-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T11:11:07Z","timestamp":1732705867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-024-01860-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1860"],"URL":"https:\/\/doi.org\/10.1038\/s41564-024-01860-1","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests. M.J.G.B., A.K., J.J. and J.P.M.L. are co-inventors on related vaccine patents. M.J.G.B., F.C., X.Y., D.v.O., L.L., W.v.d.H., J. V., A.T., R.V., J.J., L.v.d.F., R.Z. and J.P.M.L. are current or former employees of Johnson and Johnson.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}